{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:59:12Z","timestamp":1791838752178,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["The medical writing was funded by Boehringer Ingelheim"],"award-info":[{"award-number":["The medical writing was funded by Boehringer Ingelheim"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s40257-021-00652-1","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T03:02:48Z","timestamp":1642734168000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Diagnosis of Generalized Pustular Psoriasis"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8657-0618","authenticated-orcid":false,"given":"Hideki","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8926-0113","authenticated-orcid":false,"given":"Melinda","family":"Gooderham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0165-3831","authenticated-orcid":false,"given":"Ricardo","family":"Romiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"issue":"11","key":"652_CR1","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1111\/jdv.14386","volume":"31","author":"AA Navarini","year":"2017","unstructured":"Navarini AA, Burden AD, Capon F, Mrowietz U, Puig L, Koks S, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol. 2017;31(11):1792\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"652_CR2","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/exd.13699","volume":"27","author":"A Boehner","year":"2018","unstructured":"Boehner A, Navarini AA, Eyerich K. Generalized pustular psoriasis: a model disease for specific targeted immunotherapy, systematic review. Exp Dermatol. 2018;27(10):1067\u201377.","journal-title":"Exp Dermatol"},{"issue":"1","key":"652_CR3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2340\/00015555766871","volume":"76","author":"A Ohkawara","year":"1996","unstructured":"Ohkawara A, Yasuda H, Kobayashi H, Inaba Y, Ogawa H, Hashimoto I, et al. Generalized pustular psoriasis in Japan: two distinct groups formed by differences in symptoms and genetic background. Acta Derm Venereol. 1996;76(1):68\u201371.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"652_CR4","first-page":"669","volume":"16","author":"F Augey","year":"2006","unstructured":"Augey F, Renaudier P, Nicolas JF. Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol. 2006;16(6):669\u201373.","journal-title":"Eur J Dermatol"},{"issue":"11","key":"652_CR5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/1346-8138.14523","volume":"45","author":"H Fujita","year":"2018","unstructured":"Fujita H, Terui T, Hayama K, Akiyama M, Ikeda S, Mabuchi T, et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP. J Dermatol. 2018;45(11):1235\u201370.","journal-title":"J Dermatol"},{"key":"652_CR6","first-page":"37","volume":"9","author":"K Ly","year":"2019","unstructured":"Ly K, Beck KM, Smith MP, Thibodeaux Q, Bhutani T. Diagnosis and screening of patients with generalized pustular psoriasis. Psoriasis (Auckl). 2019;9:37\u201342.","journal-title":"Psoriasis (Auckl)."},{"issue":"3","key":"652_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jaci.2018.06.038","volume":"143","author":"S Twelves","year":"2019","unstructured":"Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, et al. Clinical and genetic differences between pustular psoriasis subtypes. J Allergy Clin Immunol. 2019;143(3):1021\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"652_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/ijd.12070","volume":"53","author":"SE Choon","year":"2014","unstructured":"Choon SE, Lai NM, Mohammad NA, Nanu NM, Tey KE, Chew SF. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2014;53(6):676\u201384.","journal-title":"Int J Dermatol"},{"issue":"4","key":"652_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2165\/11586900-000000000-00000","volume":"12","author":"J Borges-Costa","year":"2011","unstructured":"Borges-Costa J, Silva R, Goncalves L, Filipe P, Soares de Almeida L, Marques Gomes M. Clinical and laboratory features in acute generalized pustular psoriasis: a retrospective study of 34 patients. Am J Clin Dermatol. 2011;12(4):271\u20136.","journal-title":"Am J Clin Dermatol"},{"issue":"12","key":"652_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1365-2133.1968.tb11947.x","volume":"80","author":"H Baker","year":"1968","unstructured":"Baker H, Ryan TJ. Generalized pustular psoriasis: a clinical and epidemiological study of 104 cases. Br J Dermatol. 1968;80(12):771\u201393.","journal-title":"Br J Dermatol"},{"issue":"5","key":"652_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1365-2230.2008.03034.x","volume":"34","author":"AM Tobin","year":"2009","unstructured":"Tobin AM, Langan SM, Collins P, Kirby B. Generalized pustular psoriasis (von Zumbusch) following the use of calcipotriol and betamethasone dipropionate ointment: a report of two cases. Clin Exp Dermatol. 2009;34(5):629\u201330.","journal-title":"Clin Exp Dermatol"},{"issue":"5 Pt 2","key":"652_CR12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S0190-9622(87)70281-3","volume":"17","author":"M Katz","year":"1987","unstructured":"Katz M, Seidenbaum M, Weinrauch L. Penicillin-induced generalized pustular psoriasis. J Am Acad Dermatol. 1987;17(5 Pt 2):918\u201320.","journal-title":"J Am Acad Dermatol"},{"key":"652_CR13","unstructured":"Mirza HA, Badri T, Kwan E. Generalized pustular psoriasis. Treasure Island (FL): StatPearls; 2021."},{"issue":"16","key":"652_CR14","doi-asserted-by":"publisher","first-page":"9048","DOI":"10.3390\/ijms22169048","volume":"22","author":"D Samotij","year":"2021","unstructured":"Samotij D, Szczech J, Reich A. Generalized pustular psoriasis: divergence of innate and adaptive immunity. Int J Mol Sci. 2021;22(16):9048\u201368.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"652_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-2230.2006.02315.x","volume":"32","author":"R Goiriz","year":"2007","unstructured":"Goiriz R, Dauden E, Perez-Gala S, Guhl G, Garcia-Diez A. Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers. Clin Exp Dermatol. 2007;32(2):176\u20139.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"652_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/ced.12392","volume":"39","author":"RA Hay","year":"2014","unstructured":"Hay RA, Pan JY. Paradoxical flare of pustular psoriasis triggered by ustekinumab, which responded to adalimumab therapy. Clin Exp Dermatol. 2014;39(6):751\u20132.","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"652_CR17","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/1346-8138.16103","volume":"48","author":"M Mori","year":"2021","unstructured":"Mori M, Tobita R, Egusa C, Maeda T, Abe N, Kawakami H, et al. Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single center. J Dermatol. 2021;48(11):1745\u201353.","journal-title":"J Dermatol"},{"issue":"4","key":"652_CR18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/ijd.13489","volume":"56","author":"BW Lau","year":"2017","unstructured":"Lau BW, Lim DZ, Capon F, Barker JN, Choon SE. Juvenile generalized pustular psoriasis is a chronic recalcitrant disease: an analysis of 27 patients seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol. 2017;56(4):392\u20139.","journal-title":"Int J Dermatol"},{"issue":"2","key":"652_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.34172\/hpp.2021.32","volume":"11","author":"N Onsun","year":"2021","unstructured":"Onsun N, Kaya G, Isik BG, Gunes B. A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: case report. Health Promot Perspect. 2021;11(2):261\u20132.","journal-title":"Health Promot Perspect"},{"key":"652_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdcr.2021.08.035","volume":"17","author":"D Perna","year":"2021","unstructured":"Perna D, Jones J, Schadt CR. Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine. JAAD Case Rep. 2021;17:1\u20133.","journal-title":"JAAD Case Rep"},{"key":"652_CR21","first-page":"107","volume":"15","author":"D Samotij","year":"2021","unstructured":"Samotij D, Gawron E, Szczech J, Ostanska E, Reich A. Acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis following COVID-19: a case report of a successful treatment with infliximab in combination with acitretin. Biologics. 2021;15:107\u201313.","journal-title":"Biologics"},{"issue":"1","key":"652_CR22","doi-asserted-by":"publisher","first-page":"e14595","DOI":"10.1111\/dth.14595","volume":"34","author":"M Shahidi Dadras","year":"2021","unstructured":"Shahidi Dadras M, Diab R, Ahadi M, Abdollahimajd F. Generalized pustular psoriasis following COVID-19. Dermatol Ther. 2021;34(1):e14595.","journal-title":"Dermatol Ther"},{"issue":"7","key":"652_CR23","first-page":"574","volume":"9","author":"A Kawamura","year":"1999","unstructured":"Kawamura A, Kinoshita MT, Suzuki H. Generalized pustular psoriasis with hypoparathyroidism. Eur J Dermatol. 1999;9(7):574\u20136.","journal-title":"Eur J Dermatol"},{"key":"652_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/IJWH.S125784","volume":"10","author":"MK Trivedi","year":"2018","unstructured":"Trivedi MK, Vaughn AR, Murase JE. Pustular psoriasis of pregnancy: current perspectives. Int J Womens Health. 2018;10:109\u201315.","journal-title":"Int J Womens Health."},{"issue":"3","key":"652_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/00325481.2020.1831315","volume":"133","author":"JJ Crowley","year":"2021","unstructured":"Crowley JJ, Pariser DM, Yamauchi PS. A brief guide to pustular psoriasis for primary care providers. Postgrad Med. 2021;133(3):330\u201344.","journal-title":"Postgrad Med"},{"issue":"10","key":"652_CR26","first-page":"702","volume":"90","author":"JW Ely","year":"2014","unstructured":"Ely JW, Rosenfeld S, Seabury SM. Diagnosis and management of tinea infections. Am Fam Physician. 2014;90(10):702\u201310.","journal-title":"Am Fam Physician"},{"issue":"3","key":"652_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.cmi.2017.08.016","volume":"24","author":"M Guarana","year":"2018","unstructured":"Guarana M, Nucci M. Acute disseminated candidiasis with skin lesions: a systematic review. Clin Microbiol Infect. 2018;24(3):246\u201350.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"652_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.det.2013.04.001","volume":"31","author":"HB Naik","year":"2013","unstructured":"Naik HB, Cowen EW. Autoinflammatory pustular neutrophilic diseases. Dermatol Clin. 2013;31(3):405\u201325.","journal-title":"Dermatol Clin"},{"issue":"2","key":"652_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41423-020-0519-3","volume":"18","author":"R Uppala","year":"2021","unstructured":"Uppala R, Tsoi LC, Harms PW, Wang B, Billi AC, Maverakis E, et al. \u201cAutoinflammatory psoriasis\u201d: genetics and biology of pustular psoriasis. Cell Mol Immunol. 2021;18(2):307\u201317.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"652_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jdermsci.2014.02.006","volume":"74","author":"K Sugiura","year":"2014","unstructured":"Sugiura K. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants. J Dermatol Sci. 2014;74(3):187\u201392.","journal-title":"J Dermatol Sci"},{"issue":"12","key":"652_CR31","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1600-0560.2010.01612.x","volume":"37","author":"SH Kardaun","year":"2010","unstructured":"Kardaun SH, Kuiper H, Fidler V, Jonkman MF. The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis. J Cutan Pathol. 2010;37(12):1220\u20139.","journal-title":"J Cutan Pathol"},{"issue":"7","key":"652_CR32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365(7):620\u20138.","journal-title":"N Engl J Med"},{"issue":"11","key":"652_CR33","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.jid.2016.06.618","volume":"136","author":"SK Mahil","year":"2016","unstructured":"Mahil SK, Twelves S, Farkas K, Setta-Kaffetzi N, Burden AD, Gach JE, et al. AP1S3 mutations cause skin autoinflammation by disrupting keratinocyte autophagy and up-regulating IL-36 production. J Investig Dermatol. 2016;136(11):2251\u20139.","journal-title":"J Investig Dermatol"},{"issue":"3","key":"652_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ajhg.2020.06.020","volume":"107","author":"M Vergnano","year":"2020","unstructured":"Vergnano M, Mockenhaupt M, Benzian-Olsson N, Paulmann M, Grys K, Mahil SK, et al. Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin disease. Am J Hum Genet. 2020;107(3):539\u201343.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"652_CR35","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.jid.2019.11.024","volume":"140","author":"S Frey","year":"2020","unstructured":"Frey S, Sticht H, Wilsmann-Theis D, Gerschutz A, Wolf K, Lohr S, et al. Rare loss-of-function mutation in SERPINA3 in generalized pustular psoriasis. J Investig Dermatol. 2020;140(7):1451-5.e13.","journal-title":"J Investig Dermatol"},{"issue":"8","key":"652_CR36","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3390\/ijms17081214","volume":"17","author":"L Feldmeyer","year":"2016","unstructured":"Feldmeyer L, Heidemeyer K, Yawalkar N. Acute generalized exanthematous pustulosis: pathogenesis, genetic background, clinical variants and therapy. Int J Mol Sci. 2016;17(8):1214.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"652_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijwd.2020.02.003","volume":"6","author":"S Bhargava","year":"2020","unstructured":"Bhargava S, Kumar U, Kroumpouzos G. Subcorneal pustular dermatosis: comprehensive review and report of a case presenting during pregnancy. Int J Womens Dermatol. 2020;6(3):131\u20136.","journal-title":"Int J Womens Dermatol."},{"issue":"6","key":"652_CR38","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jaad.2019.11.059","volume":"82","author":"K Kridin","year":"2020","unstructured":"Kridin K, Patel PM, Jones VA, Cordova A, Amber KT. IgA pemphigus: a systematic review. J Am Acad Dermatol. 2020;82(6):1386\u201392.","journal-title":"J Am Acad Dermatol"},{"key":"652_CR39","unstructured":"Aslanova M, Yarrarapu SNS, Zito PM. IgA pemphigus. Treasure Island (FL): StatPearls; 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519063\/"},{"issue":"3","key":"652_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.det.2011.03.012","volume":"29","author":"KA James","year":"2011","unstructured":"James KA, Culton DA, Diaz LA. Diagnosis and clinical features of pemphigus foliaceus. Dermatol Clin. 2011;29(3):405\u201312 (viii).","journal-title":"Dermatol Clin"},{"key":"652_CR41","first-page":"93","volume":"6","author":"RK Singh","year":"2016","unstructured":"Singh RK, Lee KM, Ucmak D, Brodsky M, Atanelov Z, Farahnik B, et al. Erythrodermic psoriasis: pathophysiology and current treatment perspectives. Psoriasis (Auckl). 2016;6:93\u2013104.","journal-title":"Psoriasis (Auckl)."},{"issue":"6","key":"652_CR42","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/archdermatol.2009.100","volume":"145","author":"AA Hammerbeck","year":"2009","unstructured":"Hammerbeck AA, Daniels NH, Callen JP. Ioversol-induced acute generalized exanthematous pustulosis: a case report. Arch Dermatol. 2009;145(6):683\u20137.","journal-title":"Arch Dermatol"},{"issue":"6","key":"652_CR43","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1346-8138.2008.00484.x","volume":"35","author":"Y Matsumoto","year":"2008","unstructured":"Matsumoto Y, Okubo Y, Yamamoto T, Ito T, Tsuboi R. Case of acute generalized exanthematous pustulosis caused by ampicillin\/cloxacillin sodium in a pregnant woman. J Dermatol. 2008;35(6):362\u20134.","journal-title":"J Dermatol"},{"issue":"1","key":"652_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/ijd.IJD_581_17","volume":"63","author":"A De","year":"2018","unstructured":"De A, Das S, Sarda A, Pal D, Biswas P. Acute generalised exanthematous pustulosis: an update. Indian J Dermatol. 2018;63(1):22\u20139.","journal-title":"Indian J Dermatol"},{"key":"652_CR45","unstructured":"Trautinger F, H\u00f6nigsmann H. Chapter 35. Subcorneal pustular dermatosis (Sneddon\u2013Wilkinson disease). In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: The McGraw-Hill Companies; 2012."},{"issue":"6","key":"652_CR46","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40257-016-0202-8","volume":"17","author":"PJ Watts","year":"2016","unstructured":"Watts PJ, Khachemoune A. Subcorneal pustular dermatosis: a review of 30 years of progress. Am J Clin Dermatol. 2016;17(6):653\u201371.","journal-title":"Am J Clin Dermatol"},{"key":"652_CR47","first-page":"131","volume":"6","author":"KE Benjegerdes","year":"2016","unstructured":"Benjegerdes KE, Hyde K, Kivelevitch D, Mansouri B. Pustular psoriasis: pathophysiology and current treatment perspectives. Psoriasis (Auckl). 2016;6:131\u201344.","journal-title":"Psoriasis (Auckl)."},{"issue":"4","key":"652_CR48","first-page":"215","volume":"27","author":"A Owczarczyk-Saczonek","year":"2018","unstructured":"Owczarczyk-Saczonek A, Znajewska-Pander A, Owczarek W, Maciejewska-Radomska A, Placek W. Clinicopathologic retrospective analysis of annular pustular psoriasis. Acta Dermatovenerol Alp Pannonica Adriat. 2018;27(4):215\u20139.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat."},{"issue":"6","key":"652_CR49","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/bjd.14507","volume":"174","author":"E Burden-Teh","year":"2016","unstructured":"Burden-Teh E, Thomas KS, Ratib S, Grindlay D, Adaji E, Murphy R. The epidemiology of childhood psoriasis: a scoping review. Br J Dermatol. 2016;174(6):1242\u201357.","journal-title":"Br J Dermatol"},{"issue":"4","key":"652_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1525-1470.2010.01084.x","volume":"27","author":"ST de Oliveira","year":"2010","unstructured":"de Oliveira ST, Maragno L, Arnone M, Fonseca Takahashi MD, Romiti R. Generalized pustular psoriasis in childhood. Pediatr Dermatol. 2010;27(4):349\u201354.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"652_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000346572","volume":"226","author":"O Abbas","year":"2013","unstructured":"Abbas O, Itani S, Ghosn S, Kibbi AG, Fidawi G, Farooq M, et al. Acrodermatitis continua of Hallopeau is a clinical phenotype of DITRA: evidence that it is a variant of pustular psoriasis. Dermatology. 2013;226(1):28\u201331.","journal-title":"Dermatology"},{"issue":"10","key":"652_CR52","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/jdv.14949","volume":"32","author":"KM Hoegler","year":"2018","unstructured":"Hoegler KM, John AM, Handler MZ, Schwartz RA. Generalized pustular psoriasis: a review and update on treatment. J Eur Acad Dermatol Venereol. 2018;32(10):1645\u201351.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"652_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jdermsci.2020.03.003","volume":"98","author":"M Murakami","year":"2020","unstructured":"Murakami M, Terui T. Palmoplantar pustulosis: current understanding of disease definition and pathomechanism. J Dermatol Sci. 2020;98(1):13\u20139.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"652_CR54","doi-asserted-by":"publisher","first-page":"e006450","DOI":"10.1136\/bmjopen-2014-006450","volume":"5","author":"K Kubota","year":"2015","unstructured":"Kubota K, Kamijima Y, Sato T, Ooba N, Koide D, Iizuka H, et al. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database. BMJ Open. 2015;5(1):e006450.","journal-title":"BMJ Open"},{"issue":"9","key":"652_CR55","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/1346-8138.15467","volume":"47","author":"T Watanabe","year":"2020","unstructured":"Watanabe T, Yamaguchi Y, Watanabe Y, Takamura N, Aihara M. Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis. J Dermatol. 2020;47(9):1033\u20136.","journal-title":"J Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00652-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-021-00652-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00652-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T21:28:14Z","timestamp":1700083694000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-021-00652-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":55,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1007\/s40257-021-00652-1","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"28 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article has been published as part of a journal supplement wholly funded by Boehringer Ingelheim.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}},{"value":"Medical writing support was funded by Boehringer Ingelheim.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Hideki Fujita has received honoraria or fees for serving on advisory boards, as a speaker, and as a consultant, as well as grants as an investigator from AbbVie, Amgen, Boehringer Ingelheim, Celgene, Chugai Pharmaceutical, Esai, Eli Lilly, Janssen, Japan Blood Products Organization, JMEC, Kaken, Kyorin, Kyowa Kirin, LEO Pharma, Maruho, Mitsubishi Tanabe, Nihon Pharmaceutical, Novartis, Sanofi, Sun Pharma, Taiho, Torii, UCB, and Ushio. Melinda Gooderham has been an investigator, speaker, and\/or advisor for AbbVie, Amgen, Akros, Arcutis, Bausch Health, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Dermira, Dermavant, Eli Lilly, Galderma, GlaxoSmithKline, Incyte, Janssen, Kyowa Kirin, LEO Pharma, MedImmune, Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Genzyme, Sun Pharma, UCB, and Bausch. Ricardo Romiti has served as a scientific consultant, speaker, or clinical study investigator for AbbVie, Boehringer Ingelheim, Galderma, Janssen-Cilag, Eli-Lilly, LEO Pharma, Novartis, Pfizer, TEVA, and UCB.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"The sponsor of the supplement and all authors identified and discussed the concept for each chapter and the supplement as a whole; further development of each review article was at the direction of the authors, who provided guidance to OPEN Health Communications on the content of the article, critically revised the work, and approved the content for publication.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}